Liquidia
Trade Liquidia 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LQDA
Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.
LQDA Key Statistics
Stock Snapshot
As of today, Liquidia(LQDA) shares are valued at $27.58. The company's market cap stands at 2.51B, with a P/E ratio of 19.56.
As of 2026-10-09, Liquidia(LQDA) stock has fluctuated between $27.58 and $28.10. The current price stands at $27.58, placing the stock 0.0% above today's low and -1.9% off the high.
The Liquidia(LQDA)'s current trading volume is 12.99K, compared to an average daily volume of 8.2M.
During the past year, Liquidia(LQDA) stock moved between $21.94 at its lowest and $93.61 at its peak.
During the past year, Liquidia(LQDA) stock moved between $21.94 at its lowest and $93.61 at its peak.
LQDA News
BofA analyst Jason Gerberry lowered the firm’s price target on Liquidia (LQDA) to $38 from $40 and keeps a Neutral rating on the shares as part of the firm’s Q3...
Liquidia (LQDA) is back in focus after a U.S. District Court ruled that key claims of a United Therapeutics patent are valid and infringed by YUTREPIA, leaving...
In a regulatory filing, Liquidia (LQDA) said director Stephen Bloch sold 235,477 Liquidia shares on October 5 at an average price of $27.13, generating approxim...
Analyst ratings
56%
of 9 ratingsMore LQDA News
New insider activity at Liquidia Technologies ( (LQDA) ) has taken place on October 7, 2026. Director Stephen Bloch has cashed out a significant portion of his...
Liquidia reported that a Delaware federal court previously ruled key claims of United Therapeutics’ ‘327 patent valid and infringed by YUTREPIA, while finding o...
Liquidia Technologies (LQDA) announced an update on their ongoing clinical study. Liquidia Technologies, Inc. is running an open-label Phase 4 study called “An...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.